Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballentine

Showing results (311-320 of 357) with videos related to

Pageof 36
Sort By:
Cell Reports|March 22, 2016
α/β-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 DiabetesShangang Zhao, Yves Mugabo, Gwynne Ballentine, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
Molecular basis of antibiotic multiresistance transfer in Staphylococcus aureusJonathan S Edwards, Laurie Betts, Monica L Frazier, et al.
European Urology|October 13, 2018
Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate CancerH Ballentine Carter, Brian Helfand, Mufaddal Mamawala, et al.
Contemporary Clinical Trials|October 9, 2024
Testing Interventions for Mobility through Exercise (TIME): Study protocol for a randomized trial comparing a novel, brief home-based exercise program and a standard home-based group exercise for older adults with mobility disabilityChristopher N Sciamanna, Jordan D Kurth, William Luzier, et al.
The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
European Urology|May 24, 2020
Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical TrialHiten D Patel, Farzana A Faisal, Bruce J Trock, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1sNalin L Subasinghe, Jeremy M Travins, Farah Ali, et al.
Annals of Surgical Oncology|August 21, 2019
Correction to: Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite ExperienceDaniel Solomon, Eliahu Bekhor, Natasha Leigh, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitorsSanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Pageof 36

Showing results (311-320 of 357) with videos related to

Sort By:
Pageof 36
Cell Reports|March 22, 2016
α/β-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 DiabetesShangang Zhao, Yves Mugabo, Gwynne Ballentine, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
Molecular basis of antibiotic multiresistance transfer in Staphylococcus aureusJonathan S Edwards, Laurie Betts, Monica L Frazier, et al.
European Urology|October 13, 2018
Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate CancerH Ballentine Carter, Brian Helfand, Mufaddal Mamawala, et al.
Contemporary Clinical Trials|October 9, 2024
Testing Interventions for Mobility through Exercise (TIME): Study protocol for a randomized trial comparing a novel, brief home-based exercise program and a standard home-based group exercise for older adults with mobility disabilityChristopher N Sciamanna, Jordan D Kurth, William Luzier, et al.
The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
European Urology|May 24, 2020
Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical TrialHiten D Patel, Farzana A Faisal, Bruce J Trock, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1sNalin L Subasinghe, Jeremy M Travins, Farah Ali, et al.
Annals of Surgical Oncology|August 21, 2019
Correction to: Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite ExperienceDaniel Solomon, Eliahu Bekhor, Natasha Leigh, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitorsSanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Pageof 36